141 related articles for article (PubMed ID: 23641344)
21. Assessing the Efficacy of PLGA-Loaded Antimicrobial Peptide OH-CATH30 Microspheres for the Treatment of Bacterial Keratitis: A Promising Approach.
Jiao X; Dong X; Shan H; Qin Z
Biomolecules; 2023 Aug; 13(8):. PubMed ID: 37627308
[TBL] [Abstract][Full Text] [Related]
22. Chitosan Nanoparticles as a Mucoadhesive Drug Delivery System for Ocular Administration.
Silva MM; Calado R; Marto J; Bettencourt A; Almeida AJ; Gonçalves LMD
Mar Drugs; 2017 Dec; 15(12):. PubMed ID: 29194378
[TBL] [Abstract][Full Text] [Related]
23. Natamycin niosomes as a promising ocular nanosized delivery system with ketorolac tromethamine for dual effects for treatment of candida rabbit keratitis; in vitro/in vivo and histopathological studies.
El-Nabarawi MA; Abd El Rehem RT; Teaima M; Abary M; El-Mofty HM; Khafagy MM; Lotfy NM; Salah M
Drug Dev Ind Pharm; 2019 Jun; 45(6):922-936. PubMed ID: 30744431
[TBL] [Abstract][Full Text] [Related]
24. Experimental design, formulation and in vivo evaluation of a novel topical in situ gel system to treat ocular infections.
Nair AB; Shah J; Jacob S; Al-Dhubiab BE; Sreeharsha N; Morsy MA; Gupta S; Attimarad M; Shinu P; Venugopala KN
PLoS One; 2021; 16(3):e0248857. PubMed ID: 33739996
[TBL] [Abstract][Full Text] [Related]
25. Design and characterization of chitosan-alginate microspheres for ocular delivery of azelastine.
Shinde UA; Shete JN; Nair HA; Singh KH
Pharm Dev Technol; 2014 Nov; 19(7):813-23. PubMed ID: 24032373
[TBL] [Abstract][Full Text] [Related]
26. Investigation of moxifloxacin loaded chitosan-dextran nanoparticles for topical instillation into eye: In-vitro and ex-vivo evaluation.
Kaskoos RA
Int J Pharm Investig; 2014 Oct; 4(4):164-73. PubMed ID: 25426437
[TBL] [Abstract][Full Text] [Related]
27. Optimization and Evaluation of Gastroretentive Ranitidine HCl Microspheres by Using Factorial Design with Improved Bioavailability and Mucosal Integrity in Ulcer Model.
Khattab A; Zaki N
AAPS PharmSciTech; 2017 May; 18(4):957-973. PubMed ID: 28271373
[TBL] [Abstract][Full Text] [Related]
28. Niosomes: Do They Increase the Potency of Topical Natamycin Ketorolac Formula in Treating Aspergillus Keratitis? An Experimental Study.
El-Mofty HM; El-Nabarawi MA; Abd El Rehem RT; Teaima MH; Abary MYS; Salah M; Lotfy NM
J Ocul Pharmacol Ther; 2020 Sep; 36(7):545-554. PubMed ID: 32357092
[No Abstract] [Full Text] [Related]
29. Mucoadhesive liposomes as ocular delivery system: physical, microbiological, and in vivo assessment.
Mehanna MM; Elmaradny HA; Samaha MW
Drug Dev Ind Pharm; 2010 Jan; 36(1):108-18. PubMed ID: 19656004
[TBL] [Abstract][Full Text] [Related]
30. Gastroretentive drug delivery system of acyclovir-loaded alginate mucoadhesive microspheres: formulation and evaluation.
Shadab ; Ahuja A; Khar RK; Baboota S; Chuttani K; Mishra AK; Ali J
Drug Deliv; 2011 May; 18(4):255-64. PubMed ID: 21110695
[TBL] [Abstract][Full Text] [Related]
31. Preparation and characterization of spray-dried mucoadhesive microspheres of ketorolac for nasal administration.
Nagda CD; Chotai NP; Nagda DC; Patel SB; Patel UL
Curr Drug Deliv; 2012 Mar; 9(2):205-18. PubMed ID: 22023210
[TBL] [Abstract][Full Text] [Related]
32. Development of besifloxacin HCl loaded nanofibrous ocular inserts for the treatment of bacterial keratitis: In vitro, ex vivo and in vivo evaluation.
Polat HK; Bozdağ Pehlivan S; Özkul C; Çalamak S; Öztürk N; Aytekin E; Fırat A; Ulubayram K; Kocabeyoğlu S; İrkeç M; Çalış S
Int J Pharm; 2020 Jul; 585():119552. PubMed ID: 32569814
[TBL] [Abstract][Full Text] [Related]
33. Formulation and evaluation of an in situ gel-forming ophthalmic formulation of moxifloxacin hydrochloride.
Mandal S; Thimmasetty MK; Prabhushankar G; Geetha M
Int J Pharm Investig; 2012 Apr; 2(2):78-82. PubMed ID: 23119236
[TBL] [Abstract][Full Text] [Related]
34. Formulation, Statistical Optimization, and
Noreen S; Hasan S; Ghumman SA; Anwar S; Gondal HY; Batool F; Noureen S
ACS Omega; 2023 Feb; 8(6):5925-5938. PubMed ID: 36816641
[TBL] [Abstract][Full Text] [Related]
35. Effect of Mucoadhesive Polymeric Formulation on Corneal Permeation of Fluoroquinolones.
Gade SK; Shivshetty N; Sharma N; Bhatnagar S; Garg P; Venuganti VVK
J Ocul Pharmacol Ther; 2018 Oct; 34(8):570-578. PubMed ID: 30136888
[TBL] [Abstract][Full Text] [Related]
36. Formulation, development, and performance evaluation of metoclopramide HCl oro-dispersible sustained release tablet.
Kasliwal N; Negi JS; Jugran V; Jain R
Arch Pharm Res; 2011 Oct; 34(10):1691-700. PubMed ID: 22076769
[TBL] [Abstract][Full Text] [Related]
37. Contact lenses with dual drug delivery for the treatment of bacterial conjunctivitis.
Maulvi FA; Singhania SS; Desai AR; Shukla MR; Tannk AS; Ranch KM; Vyas BA; Shah DO
Int J Pharm; 2018 Sep; 548(1):139-150. PubMed ID: 29960036
[TBL] [Abstract][Full Text] [Related]
38. Formulation Design, Optimization and Pharmacodynamic Evaluation of Sustained Release Mucoadhesive Microcapsules of Venlafaxine HCl.
Swain S; Behera A; Dinda SC; Patra CN; Jammula S; Beg S; Rao ME
Indian J Pharm Sci; 2014 Jul; 76(4):354-63. PubMed ID: 25284934
[TBL] [Abstract][Full Text] [Related]
39. Endophthalmitis Prophylaxis Using a Single Drop of Thermoresponsive Controlled-Release Microspheres Loaded with Moxifloxacin in a Rabbit Model.
Mammen A; Romanowski EG; Fedorchak MV; Dhaliwal DK; Shanks RM; Kowalski RP
Transl Vis Sci Technol; 2016 Dec; 5(6):12. PubMed ID: 27933222
[TBL] [Abstract][Full Text] [Related]
40. Mucoadhesive microspheres containing anti-hypertensive agent: formulation and characterization.
Patel AS; Saikat P; Pravinbhai PR
Curr Drug Deliv; 2014; 11(3):322-31. PubMed ID: 24410197
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
